|
|
||||||||
J Thorac Cardiovasc Surg 2006;131:843-852
© 2006 The American Association for Thoracic Surgery
Evolving Technology |
a Institut National de la Santé et de la Recherche Médicale (Inserm) ERI-9, Faculté de Médecine, Lille, France
b Centre Hospitalier Régional Universitaire de Lille, Clinique de Chirurgie Cardiovasculaire, Lille, France
c Institut d'Hématologie-Transfusion, Lille, France
Received for publication August 5, 2005; revisions received November 20, 2005; accepted for publication November 28, 2005. * Address for reprints: André Vincentelli, MD, PhD, Clinique de Chirurgie Cardio-vasculaire, Hôpital Cardiologique, 59037 Lille cedex (Email: a-vincentelli{at}chru-lille.fr).
| Abstract |
|---|
|
|
|---|
METHODS: Decellularized porcine aortic valves were implanted in 12 lambs. Six lambs received granulocyte colony-stimulating factor (10 µg · kg1 · d1 for 7 days, granulocyte colony-stimulating factor group), and 6 received no granulocyte colony-stimulating factor (control group). Additionally, nondecellularized porcine valves were implanted in 5 lambs (xenograft group). Angiographic and histologic evaluation was performed at 3, 6, 8, and 16 weeks.
RESULTS: Few macroscopic modifications of leaflets and the aortic wall were observed in the control group, whereas progressive shrinkage and thickening of the leaflets appeared in the granulocyte colony-stimulating factor and xenograft groups. In the 3 groups progressive ovine cell infiltration (fluorescence in situ hybridization) was observed in the leaflets and in the adventitia and the intima of the aortic wall but not in the media. Neointimal proliferation of
-actinpositive cells, inflammatory infiltration, adventitial neovascularization, and calcifications were more important in the xenograft and the granulocyte colony-stimulating factor groups than in the control group. Continuous re-endothelialization appeared only in the control group.
CONCLUSION: Decellularized xenogeneic heart valve scaffolds allowed partial autologous recellularization. Granulocyte colony-stimulating factor led to accelerated heart valve deterioration similar to that observed in nondecellularized xenogeneic cardiac bioprostheses.
| Introduction |
|---|
|
|
|---|
The strategy to promote the recolonizing process remains questionable. First experiments were conducted with differentiated vascular cells (endothelial cells or smooth muscle cells) obtained from samples of saphenous veins or autologous carotid arteries.
2,6
More recently, bone marrow (BM) cells have been demonstrated to contain various progenitor cells, such as endothelial progenitors and mesenchymal lineage cells, which can induce tissue regeneration when injected into cardiovascular structures.
7
Cardiac valve interstitial cells are myofibroblasts of mesenchymal origin, and it was demonstrated that BM cells could recolonize synthetic valve scaffolds in vitro, thus confirming that BM cells contain proper cell progenitors for heart valve reconstruction.
8,9
Early BM progenitor cells can be mobilized by growth factors, such as granulocyte colony-stimulating factor (G-CSF), into peripheral blood. Numerous experimental studies have shown that G-CSFmobilized BM cells are able to home to injured cardiovascular tissues and contribute to tissue regeneration, especially in infarcted myocardium and hind-limb ischemic areas.
10,11
The aim of this study was to examine the spontaneous in vivo recolonization potential of xenogeneic decellularized heart valves in a lamb model and the effects of G-CSF mobilization of BM cells on this process.
| Methods |
|---|
|
|
|---|
Study Design
In 17 lambs (Romanov/Ile de France; aged 12-16 weeks; median weight, 23 kg) a porcine aortic valve conduit was implanted in the descending thoracic aorta. Five lambs received a nondecellularized porcine valve (xenograft group). Twelve lambs received a decellularized porcine valve. Among them, 6 received subcutaneous injections of G-CSF (Neupogen, a kind gift from Amgen Laboratories) (10 µg/kg for 7 days, from day 3 before to day 3 after the operation; G-CSF group), and 6 received no G-CSF (control group).
Surgical Techniques
In all animals general anesthesia was induced and maintained by means of intravenous injection of propofol, 20 mg/kg, and sufentanil, 1 µg/kg. All animals were operated on by the same team of surgeons (AV and FJ). The descending aorta was exposed through a left anterolateral thoracotomy, entering the chest through the fourth intercostal space. The aorta was dissected and exposed at the level of the isthmus. Two 4-0 monofilament purse strings were made on the aortic arch and distally on the descending aorta (Prolene, Ethicon, Inc). Systemic anticoagulation was induced with heparin (200 UI/kg), and a 14-mm diameter pediatric gastric tube was implanted between the aortic arch and the thoracic descending aorta as an aorticoaortic shunt. Then the aorta was crossclamped proximally immediately after the origin of the left subclavian artery and 15 cm distally. The descending aorta was transected, and the porcine aortic valve conduit was inserted with 2 end-to-end 4-0 monofilament running sutures. On completion of the operation, heparin was reversed with protamine (200 UI/kg). The chest was closed in layers, and a chest tube was inserted. The chest tube was removed after extubation. Animals were then settled in standard conditions, with food and drink ad libitum. All animals received 1000 mg of ceftriaxon and 500 mg of aspirin for the first postoperative week on a daily basis. For pain control, during the first 2 operative days, a transdermal fentanyl patch was applied on the chest. All the animals received humane care in compliance with the "Guide for the Care and Use of Laboratory Animals" published by the National Institutes of Health (National Institutes of Health publication no. 85-23, revised 1985).
Valve Follow-up and Explantation Process
In each group euthanasia was performed in one lamb at 3, 6, and 8 weeks and in the remaining animals at 16 weeks after implantation. Euthanasia was performed under the same protocol of analgesia and anesthetic procedures as for implantation. Before termination, heparin (300 UI/kg) was administrated, and an aortography was realized in each animal after catheterization of the femoral artery to detect graft abnormalities (thrombosis, aneurysm, and stenosis) and to measure the transvalvular gradient. Grafts were explanted together with the descending thoracic aorta.
Valve Analysis
Explanted valve conduits were grossly examined. Aneurysmal aortic dilatation, thickness, and retraction of the cusps and the presence of visible calcifications were reported. Then fragments from the grafted aortic wall and cusps were sampled for cytologic analysis of colonizing cells and histologic analysis.
For histology, samples were fixed in a buffered 4% formaldehyde solution, dehydrated, and embedded in paraffin. Sections (6 µm) were stained with hematoxylin, eosin, and safran and with Masson trichrome. For analysis of the intima/media ratio, computed planimetry was realized through Perfect Image 7.10 software (Clara Vision). In addition, orcein staining for elastic fibers and Von Kossa staining for calcium were performed.
Immunostaining of the paraffin sections was done with monoclonal antibody to
-actin (1:20, 1 night at +4°C) or with polyclonal antibody to VWF (1:500, 2 hours at room temperature; DAKO) and respective isotope-matched IgG control (Cymbus Biotechnology). The immunoreaction was detected with alkaline phosphatase for
-actin and with Avidin Biotin performed Complex peroxidase for VWF. The tissue sections were analyzed by 2 independent observers (DC and BJ) who were blinded to the animal group allocation.
Cytologic Analysis and Molecular Probes
For cell isolation, tissue samples were digested for 45 minutes at 37°C in a solution containing type I collagenase, elastase, and soybean trypsin inhibitor. After addition of 30% fetal calf serum, cytocentrifuged preparations were made and frozen at 70°C. Fluorescence in situ hybridization was performed with a bacterial artificial chromosome (BAC 31EA; a kind gift of Dr François Piumi, Institut National de Recherche Agronomique, Jouy en Josas, France) to detect the presence of cells of ovine origin in the samples. The ovine pancentromeric probe was labeled in red by means of nick-translation (Spectrum Red dUTP and Nick Translation Reagent kit, Vysis Inc). The slides were fixed, treated with mild pepsin solution, and dehydrated. After denaturation, identification of the centromers was performed by means pf overnight hybridization at 37°C. After washing, DNA was counterstained in blue with 4',6 diamino-2-phenylindole. A red labeling of the chromosomes was observed in all ovine cells, and no labeling was observed in porcine cells.
Statistical Analysis
Statistical analysis was performed with Statview software (SAS Institute Inc). Continuous variables were expressed as means ± standard deviations. The Wilcoxon test was used to compare individual blood cell values over the time course of the experiments. The Kruskall-Wallis test was used to analyze differences in the intima/media ratio among the 3 groups.
| Results |
|---|
|
|
|---|
.04).
|
|
|
|
-Actin staining showed numerous positive cells in the neointima (Figure 5, D). No cell was visible in the media at any time. No modification of the elastic fibers was observed (orcein staining; Figure 6, A). Rare microcalcifications appeared after 16 weeks in the junction between adventitia and media (Von Kossa staining; Figure 6, B). A continuous endothelial layer was seen on the luminal surface after 6 weeks and up to 16 weeks on the aortic wall and the leaflets (VWF staining; Figure 6, C). Few cells were observed in the leaflets (Figure 6, D), some of them being positive for
-actin staining.
|
|
-actinpositive cells (Figure 5, C and D). Necrotic zones were visible in the media, which remained acellular. Elastic fibers exhibited a progressive disorganization, thickening, and fragmentation (orcein staining; Figure 6, A). Von Kossa staining showed microcalcifications in the aortic wall and in the leaflets after 6 weeks. Elastic fiber disorganization and heavy calcifications at the adventitia-media and the media-neointima junctions were observed (Figure 6, B). VWF staining showed only a discontinuous endothelial cell layer on the luminal surface (Figure 6, C). Necrosis and inflammatory infiltration was also visible in the leaflets associated with calcifications (Figure 6, D). In the xenograft group a marked inflammatory infiltration and neovascularization was observed in the adventitia as soon as after 3 weeks and increased up to 16 weeks (Figure 5, A and B). Calcifications were visible as soon as 6 weeks. At 16 weeks, the aortic wall and leaflets exhibited features similar to those of the G-CSF group, with marked neointimal thickening (Figure 5, C and D), disorganization of elastic fibers (Figure 6, A), calcifications both in the aortic wall and the leaflets (Figure 6, B and D), and discontinuous endothelialization (Figure 6, C).
Comparison of the neointima/media thickness showed that the intima/media ratio increased continuously with time in the 3 groups. This increase was more rapid and pronounced in the xenograft group and the G-CSF group than in the decellularized group at 3 weeks (Figure 7). However, at 16 weeks, the intima/media ratio tended to be the same in the 3 groups.
|
|
| Discussion |
|---|
|
|
|---|
As a biologic extracellular matrix scaffold, we chose porcine heart valves for their well-known good hemodynamic behavior and unlimited availability. When used as valve prostheses, these porcine scaffolds are usually treated with glutaraldehyde to improve mechanical properties and to limit the xenogeneic rejection process. However, glutaraldehyde treatment profoundly modifies the extracellular matrix structure and makes it improper to support cell migration, recolonization, and the matrix-renewing process.
14
Decellularization of porcine valves is another approach to limit cell-mediated xenograft rejection and potentially facilitate recolonization by interstitial cells. Several decellularization processes have been described, leading to important differences in the efficiency of cell removal, long-term mechanical properties, and xenoantigen residual exposition.
15,16
It is noteworthy that in a series of 4 young patients, enzymatic decellularization of porcine grafts have shown severe drawbacks associated with catastrophic clinical results, such as rapid graft failure, that were responsible for the death of two thirds of the patients.
17,18
By contrast, homografts decellularized with the same enzymatic process (Synergraft, Cryolife Inc) and implanted in adults have shown better outcome.
19
Furthermore, the postmortem analysis of a Synergraft-treated homograft explanted 5 weeks after implantation in a 60-year-old patient showed preserved morphology, although associated with inflammatory infiltration.
20
In our study we used porcine xenografts decellularized through a nonenzymatic process on the basis of osmotic shock, detergent cell extraction (0.1% sodium dodecylsulfate), and antiproteases recently described by Korossis and colleagues,
12
which induced complete decellularization without major impairment of the structural proteins. Under that process, valve conduit tissues had equal strength compared with fresh tissues and only modest changes in extensibility in vitro.
13
In addition, this process was recently demonstrated to remove xenoantigens.
21
Using that protocol, we observed a complete tissue decellularization before implantation, and this observation was further confirmed after explantation because all the cells eluted from the explanted valves were positive for the ovine centromeric probe, demonstrating their ovine origin.
Such decellularized scaffolds were recently demonstrated in vitro to allow cell recolonization by smooth muscle cells without cytotoxicity.
5
Our study analyzes for the first time the ability of this decellularized scaffold to be recolonized in vivo by nonporcine cells. Because high mechanical forces must be sustained by the aortic valve conduit, we implanted the scaffolds in the descending aorta of lambs to evaluate its resistance to physiologic strains in vivo. As previously reported by Korossis and colleagues
12
in vitro, we observed that these scaffolds have a good mechanical resistance in vivo, with no aneurysm formation and no rupture. We chose, in this study, to implant the porcine scaffolds in the descending aorta of lambs, where systemic strains are very high. Such an implantation site allows us to test the aortic root resistance to high mechanical strains but does not allow evaluation of the aortic leaflet functions.
We observed a limited recolonization associated with weak inflammatory reaction, no visible calcifications, and delayed neointimal proliferation, suggesting that this scaffold could be suitable for in vivo homing. Whether these cells can produce collagen to repair the valve remains to be investigated. Moreover, the media of the aortic wall remained acellular, and although delayed, neointimal proliferation was comparable with that of nondecellularized grafts after 16 weeks.
In an attempt to optimize scaffold recolonization, a group of lambs received G-CSF, a growth factor routinely used in human clinical applications, which can mobilize multipotent progenitor cells from BM into peripheral blood. In myocardial infarction beneficial effects of G-CSF, such as decreased left ventricular remodeling and improved myocardial function, have been obtained in animal models.
22-24
The advocated mechanisms for these beneficial effects are improvement of the postinfarct healing process through increased macrophage infiltration, promotion of reparative collagen synthesis in the infarct area, inhibition of apoptosis, and increased neovascularization.
25
G-CSF has also been demonstrated to improve endothelialization of vascular grafts in dogs,
26
suggesting that it could mobilize early progenitors for endothelial cells. Moreover, it was recently demonstrated that G-CSF mobilizes functional endothelial progenitor cells in patients with coronary disease.
27
Because human G-CSF had not been tested previously in lambs, we first verified that it could induce a significant increase in peripheral white blood cell counts in our model. The observed increase was significant, although less pronounced than in human subjects.
28
Unfortunately, immunologic identification of stem cells was not possible in this model because available human antibodies against human or mouse stem cell antigens do not react with sheep stem cells. In grafted decellularized heart valves, G-CSF induced an increase in inflammatory cell infiltration and neovessel formation in the adventitia, myointimal proliferation, and calcifications, both in leaflets and the aortic wall, indicating deleterious effects on valve outcome.
Several mechanisms could account for these observations. G-CSF is a physiologic component of the acute-phase response, and its primary effect is the mobilization of neutrophil granulocytes.
29
G-CSFmobilized cells also contain a significantly higher proportion of monocytes than normal peripheral blood and of accessory cells, particularly T-cell subsets. Therefore G-CSF can mobilize various subsets of mature effector cells of the immune and inflammatory response, which could amplify the immune and inflammatory reaction against residual extracellular matrix antigens of the decellularized scaffold. Although the decellularization process we used has been shown to be the most effective on xenoantigen removal,
21
recent data indicate that porcine scaffolds decellularized with a similar method keep a significant potential to attract monocytes and promote their migration in extracellular matrix.
16
Therefore the deleterious effects of G-CSF could be related to a dramatic increase of leukocyte-mediated immune and inflammatory reaction against residual xenoantigens, as observed in nondecellularized xenografts. Decellularized allogeneic valves could provide more adequate scaffolds for autologous recellularization, as recently demonstrated.
16
The effects of G-CSF on such allogeneic scaffolds remain to be investigated.
It is noteworthy that the deleterious effects of G-CSF have recently been described in a clinical assay in myocardial infarction in human subjects, in whom G-CSF treatment resulted in increased restenosis rates after coronary stenting.
30
We also observed an increased myointimal proliferation in the grafted aortic wall, as well as increased neovessel formation in the adventitia, indicating that G-CSF induces significant and potentially deleterious effects in the aortic wall remodeling process. Although we did not observe any aneurysmal formation, such an early inflammatory reaction could lead to significant weakening of the valve prosthesis and to accelerated valve failure.
The immature sheep model has been used for years for testing bioprosthetic tissue, which degenerates rapidly, as in young patients, with morphology similar to that seen in clinical specimen. Although porcine valve scaffolds decellularized through a nonenzymatic method underwent relatively safe outcome, the extrapolation of data from any animal model to human valve implantation requires caution. Human applications will require additional long-term data because previous results of implantation of tissue-engineered porcine heart valves in pediatric patients have been catastrophic.
18
Further studies will be required.
In conclusion, we demonstrate that xenogeneic porcine heart valves decellularized through a nonenzymatic process allow partial spontaneous autologous recolonization, with delayed and limited inflammation and calcifications. However, the recolonization process remains limited, suggesting that further improvement of the extracellular scaffold is mandatory before human implantation. In this setting G-CSF accelerated valve deterioration through increased inflammatory reaction and calcifications. Further studies shouldconsider alternative strategies to improve scaffold recolonization without inducing adverse effects on valve outcome.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
F. Godart, I. Bouzguenda, F. Juthier, F. Wautot, A. Prat, C. Rey, D. Corseaux, A. Ung, B. Jude, and A. Vincentelli Experimental off-pump transventricular pulmonary valve replacement using a self-expandable valved stent: A new approach for pulmonary incompetence after repaired tetralogy of Fallot? J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1141 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Madonna and R. De Caterina In vitro neovasculogenic potential of resident adipose tissue precursors Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1271 - C1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vincentelli, F. Juthier, and B. Jude Reply to the editor. J. Thorac. Cardiovasc. Surg., June 1, 2008; 135(6): 1407 - 1407. [Full Text] [PDF] |
||||
![]() |
A. Vincentelli, F. Wautot, F. Juthier, O. Fouquet, D. Corseaux, S. Marechaux, T. Le Tourneau, O. Fabre, S. Susen, E. Van Belle, et al. In vivo autologous recellularization of a tissue-engineered heart valve: Are bone marrow mesenchymal stem cells the best candidates? J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 424 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stamm and G. Steinhoff When less is more: Go slowly when repopulating a decellularized valve in vivo! J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 735 - 737. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |